BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Whittle MC, Hingorani SR. Runx3 and Cell Fate Decisions in Pancreas Cancer. Adv Exp Med Biol 2017;962:333-52. [PMID: 28299667 DOI: 10.1007/978-981-10-3233-2_21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Szmajda-Krygier D, Krygier A, Jamroziak K, Korycka-Wołowiec A, Żebrowska-Nawrocka M, Balcerczak E. RUNX1 and RUNX3 Genes Expression Level in Adult Acute Lymphoblastic Leukemia-A Case Control Study. Curr Issues Mol Biol 2022;44:3455-64. [PMID: 36005134 DOI: 10.3390/cimb44080238] [Reference Citation Analysis]
2 Gao J, Meng C, Guan L, Zhang H, Zhang W. Astragaloside IV promotes cardiac remodeling after myocardial infarction by inhibiting DNMT3B-mediated Runx3 methylation via downregulating LncRNA MIRT1 expression. Food Sci Technol 2022;42:e44721. [DOI: 10.1590/fst.44721] [Reference Citation Analysis]
3 Sweeney K, Cameron ER, Blyth K. Complex Interplay between the RUNX Transcription Factors and Wnt/β-Catenin Pathway in Cancer: A Tango in the Night. Mol Cells 2020;43:188-97. [PMID: 32041394 DOI: 10.14348/molcells.2019.0310] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Date Y, Ito K. Oncogenic RUNX3: A Link between p53 Deficiency and MYC Dysregulation. Mol Cells 2020;43:176-81. [PMID: 31991537 DOI: 10.14348/molcells.2019.0285] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
5 Steponaitis G, Kazlauskas A, Vaitkienė P, Deltuva VP, Mikuciunas M, Skiriutė D. Oncosuppressive Role of RUNX3 in Human Astrocytomas. J Oncol 2019;2019:1232434. [PMID: 31467531 DOI: 10.1155/2019/1232434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Lee Y, Lee H, Park H, Kim JW, Hwang JH, Kim J, Yoon YS, Han HS, Kim H. Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas. Oncotarget 2017;8:76699-711. [PMID: 29100342 DOI: 10.18632/oncotarget.20815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]